A comprehensive view of United Therapeutics Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

UNITED THERAPEUTICS CORP - (8-K) - Disclosing Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

'Treprostinil Prodrugs' in Patent Application Approval Process (USPTO 20240051979)

United Therapeutics Corp. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405]: (Feb. 21, 2024)

United Therapeutics Corporation - Material Event - Form 8-K

UNITED THERAPEUTICS CORP - (8-K) - Disclosing Other Events

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count